Clinical Trial Update: Reinforcement Learning for Warfarin Dosing [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial on reinforcement learning for warfarin dosing was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clotting Disorder

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: University of Louisville | Conditions: Clotting Disorder | Phase 4 | Status: WITHDRAWN